Exhibit 99.1
3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance
Sales of $6.3 billion, down 0.5% YoY
Adjusted sales of $6.0 billion with organic growth up 1.2% YoY
GAAP EPS from continuing operations of $2.17, up 117% YoY
Adjusted EPS from continuing operations of $1.93, up 39% YoY
Operating cash flow of $1.0 billion with adjusted free cash flow of $1.2 billion
Updates full-year 2024 adjusted EPS from continuing operations to $7.00 to $7.30 from $6.80 to $7.30
ST. PAUL, Minn. – July 26, 2024 − 3M (NYSE: MMM) today reported second-quarter results.
“We delivered another strong quarter with adjusted earnings growth up double-digits and robust cash generation. I want to thank 3M employees for their exceptional execution, which we expect to continue in the second half of the year,” said William Brown, 3M Chief Executive Officer. “As I look ahead, I am focused on three priorities: driving sustained organic revenue growth, increasing operational performance, and effectively deploying capital. I have long admired 3M’s track record of innovation and am excited to be leading this great company and by the opportunities ahead.”
Second-Quarter Highlights:
Q2 2024
Q2 2023
GAAP EPS from continuing operations (GAAP EPS)$2.17 $(12.94)
Special items:
Net costs for significant litigation 0.44 14.43 
(Increase) decrease in value of Solventum ownership(2.00)— 
Pension risk transfer charge1.09 — 
Other special items, net0.23 (0.10)
Adjusted EPS from continuing operations (Adjusted EPS)$1.93 $1.39 
Memo:
GAAP operating income margin20.3 %(148.9)%
Adjusted operating income margin21.6 %17.2 %
GAAP EPS of $2.17 and operating margin of 20.3%.
Adjusted EPS of $1.93, up 39% year-on-year.
Adjusted operating income margin of 21.6%, an increase of 4.4 percentage points year-on-year.
GAAPAdjusted (Non-GAAP)
Net sales (Millions)$6,255$6,019
Sales change
Total sales (0.5)%1.1%
Components of sales change:
Organic sales1
(0.3)%1.2%
Acquisitions/divestitures1.2%1.3%
Translation(1.4)%(1.4)%
Adjusted sales excludes manufactured PFAS products.
1Above adjusted organic sales increase includes a 120 basis point headwind from product portfolio initiatives and exit of certain small countries.
Sales of $6.3 billion, down 0.5% year-on-year, with organic sales down 0.3% year-on-year.
Adjusted sales of $6.0 billion, up 1.1% year-on-year with adjusted organic sales up 1.2% year-on-year.
Operating cash flow of $1.0 billion; adjusted free cash flow of $1.2 billion.
3M returned $786 million to shareholders via dividends and share repurchases.
This document includes reference to certain non-GAAP measures. See the “Supplemental Financial Information Non-GAAP Measures” section for applicable information.
1


Updated Full-Year 2024 Earnings Outlook
3M updated its full-year adjusted earnings expectations given the company’s strong operational execution in the first half of the year. The 2024 earnings outlook below reflects the continuing operations of 3M.

Prior 2024 forecast2
Current 2024 forecast2
Adjusted total sales growth(0.25%) to +1.75%(0.25%) to +1.75%
Adjusted organic sales growthflat to +2%flat to +2%
Adjusted EPS
$6.80 to $7.30$7.00 to $7.30
2As further discussed at 6 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.
Conference Call
3M will conduct an investor teleconference at 9 a.m. EDT (8 a.m. CDT) today. Investors can access this conference via the following:
Live webcast at https://investors.3M.com
Webcast replay at https://investors.3m.com/financials/quarterly-earnings
Forward-Looking Statements
This news release contains forward-looking statements. You can identify these statements by the use of words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “would,” “forecast” and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation, recession, military conflicts, and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as “PFAS,” including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement to resolve claims by public water suppliers in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q and 8-K (the “Reports”); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company’s Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential business disruption; the diversion of management time; the impact of the transaction on the Company's ability to retain talent; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; the risk that any consents or approvals required will not be obtained; risks under the agreements and obligations entered into in connection with the spin-off, and (16) matters relating to Combat Arms Earplugs (“CAE”), including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company’s subsidiary Aearo Technologies and certain of its affiliates and/or the Company. A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.
2

3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME (LOSS)
(Millions, except per-share amounts)
(Unaudited)

Three months ended
June 30,
Six months ended
June 30,
(Millions, except per share amounts)2024202320242023
Net sales$6,255 $6,283 $12,271 $12,338 
Operating expenses
Cost of sales3,571 3,728 7,056 7,472 
Selling, general and administrative expenses1,132 11,615 2,260 12,763 
Research, development and related expenses 280 298 534 595 
Total operating expenses 4,983 15,641 9,850 20,830 
Operating income (loss)1,272 (9,358)2,421 (8,492)
Other expense (income), net(138)72 82 128 
Income (loss) from continuing operations before income taxes1,410 (9,430)2,339 (8,620)
Provision (benefit) for income taxes 203 (2,261)423 (2,116)
Income (loss) from continuing operations of consolidated group1,207 (7,169)1,916 (6,504)
Income (loss) from unconsolidated subsidiaries, net of taxes3 4 
Net income (loss) from continuing operations including noncontrolling interest 1,210 (7,166)1,920 (6,499)
Less: Net income (loss) attributable to noncontrolling interest 6 11 10 
Net income (loss) from continuing operations attributable to 3M1,204 (7,171)1,909 (6,509)
Net income (loss) from discontinued operations, net of taxes
(59)330 164 644 
Net income (loss) attributable to 3M $1,145 $(6,841)$2,073 $(5,865)
Earnings (loss) per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic553.8 553.9 554.4 553.3 
Earnings (loss) per share from continuing operations — basic
$2.17 $(12.94)$3.44 $(11.76)
Earnings (loss) per share from discontinued operations — basic
(0.10)0.59 0.30 1.16 
Earnings (loss) per share — basic
$2.07 $(12.35)$3.74 $(10.60)
Weighted average 3M common shares outstanding — diluted554.8 553.9 555.3 553.3 
Earnings (loss) per share from continuing operations — diluted
$2.17 $(12.94)$3.44 $(11.76)
Earnings (loss) per share from discontinued operations — diluted
(0.10)0.59 0.29 1.16 
Earnings (loss) per share — diluted $2.07 $(12.35)$3.73 $(10.60)
3

3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
June 30,
2024
December 31,
2023
ASSETS
Current assets
Cash and cash equivalents$10,083 $5,735 
Marketable securities – current255 50 
Accounts receivable – net3,575 3,601 
Inventories4,060 3,944 
Prepaids444 344 
Other current assets1,098 326 
Current assets of discontinued operations 2,379 
Total current assets19,515 16,379 
Property, plant and equipment – net7,472 7,690 
Operating lease right of use assets610 657 
Goodwill and intangible assets – net7,584 7,705 
Other assets8,196 6,806 
Non-current assets of discontinued operations 11,343 
Total assets$43,377 $50,580 
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt$1,302 $2,947 
Accounts payable2,813 2,776 
Accrued payroll602 695 
Accrued income taxes407 304 
Operating lease liabilities – current169 192 
Other current liabilities9,052 6,660 
Current liabilities of discontinued operations 1,723 
Total current liabilities14,345 15,297 
Long-term debt11,781 13,088 
Other liabilities13,263 16,641 
Non-current liabilities of discontinued operations 686 
Total liabilities39,389 45,712 
Total equity3,988 4,868 
Shares outstanding
June 30, 2024: 549,353,621
December 31, 2023: 552,581,136
Total liabilities and equity$43,377 $50,580 
4

3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
Six months ended June 30,
20242023
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES$1,788 $2,784 
Cash flows from investing activities:
Purchases of property, plant and equipment(644)(852)
Purchases and proceeds from sale or maturities of marketable securities and investments – net(236)170 
Other investing activities24 63 
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES(856)(619)
Cash flows from financing activities:
Change in debt – net
5,509 (44)
Purchases of treasury stock(421)(29)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans30 218 
Dividends paid to shareholders(1,221)(1,655)
Cash transferred to Solventum related to separation, net
(577)— 
Other financing activities(57)(9)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES3,263 (1,519)
Effect of exchange rate changes on cash and cash equivalents(45)(43)
Net increase (decrease) in cash and cash equivalents4,150 603 
Cash and cash equivalents at beginning of year5,933 3,655 
Cash and cash equivalents at end of period$10,083 $4,258 
The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.
5

3M Company and Subsidiaries
SALES CHANGE ANALYSIS3
(Unaudited)
Three months ended June 30, 2024
Sales Change Analysis By Geographic AreaAmericasAsia PacificEurope, Middle East and AfricaWorldwide
Organic sales0.7 %0.6 %(4.6)%(0.3)%
Acquisitions0.5 0.2 — 0.4 
Divestitures1.6 0.1 0.1 0.8 
Translation(0.3)(4.0)(0.7)(1.4)
Total sales change2.5 %(3.1)%(5.2)%(0.5)%
Six months ended June 30, 2024
Sales Change Analysis By Geographic AreaAmericasAsia PacificEurope, Middle East and AfricaWorldwide
Organic sales(0.6)%1.1 %(1.6)%(0.3)%
Acquisitions0.7 0.1 — 0.4 
Divestitures0.8 — (0.1)0.4 
Translation0.1 (4.0)0.4 (1.0)
Total sales change1.0 %(2.8)%(1.3)%(0.5)%
Three months ended June 30, 2024
Worldwide Sales Change By Business SegmentOrganic salesAcquisitionsDivestituresTranslationTotal sales
change
Safety and Industrial1.1 %— %— %(1.3)%(0.2)%
Transportation and Electronics(1.3)1.0 — (1.9)(2.2)
Consumer(1.4)— — (1.0)(2.4)
Six months ended June 30, 2024
Worldwide Sales Change By Business SegmentOrganic salesAcquisitionsDivestituresTranslationTotal sales
change
Safety and Industrial(0.2)%— %— %(0.7)%(0.9)%
Transportation and Electronics0.6 1.2 — (1.6)0.2 
Consumer(2.6)— — (0.7)(3.3)
3Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
6

3M Company and Subsidiaries
BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION
(Unaudited)
3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M operating income (loss) and income before taxes. Business segment operating income (loss) excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated and Other”).
3M made certain changes to the composition of segment information reviewed by 3M's chief operating decision maker (CODM) effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its business segments effective in the first quarter of 2024. Accordingly, information provided herein reflects the impact of these changes for all applicable periods presented.
Effective in the second quarter of 2024, this change included the following:
Elimination of former Health Care business segment
The former Health Care business segment was eliminated in the second quarter of 2024 in connection with the separation of Solventum and reflection of its historical net income and applicable assets and liabilities included in the Separation as discontinued operations within 3M's financial statements.
Addition of ‘Other’ and update to ‘Corporate and Unallocated’
3M added the “Other” category of information as a result of the Separation. It principally reflects activity associated with:
Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Separation, as well as other applicable divestitures.
Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with those previous divestitures.
Activity included in 3M’s existing “Corporate and Unallocated” was updated primarily to additionally reflect:
Removal of costs related to separating and divesting Solventum that were eligible to be part of discontinued operations.
Commercial activity with Solventum post-Separation and certain operations of the former Health Care business segment retained by 3M.
Costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations (and prospectively, post-spin, became additional costs allocated to remaining business segments) other than those beginning in the first quarter of 2024 included in “Other” associated with transition arrangement activity for which 3M began to charge fees in April 2024.
In addition, effective in the first quarter of 2024, 3M made certain changes within its business segments as described below. While they impacted the composition of certain divisions within business segments, they did not change the overall composition of segments or the measure of segment operating performance used by 3M’s CODM.
Creation of Industrial Specialties division (within Safety and Industrial business segment) and Commercial Branding and Transportation division (within Transportation and Electronics business segment)
3M created the Industrial Specialties division within the Safety and Industrial business segment, which consists of the former Closure and Masking Systems division along with certain products formerly within the Industrial Adhesive and Tapes division and the Personal Safety division. Further, 3M created the Commercial Branding and Transportation division within the Transportation and Electronics business segment, which consists of the former Commercial Solutions division and the Transportation Safety division.
Re-alignment of divisions within Consumer business segment
Within the Consumer business segment, the business re-aligned to the following four divisions: Consumer Safety and Well-Being, Home and Auto Care, Home Improvement, and Packaging and Expression.
7

3M Company and Subsidiaries
BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION - (CONTINUED)
(Unaudited)

BUSINESS SEGMENT INFORMATIONThree months ended
June 30,
Six months ended
June 30,
NET SALES
(Millions)2024202320242023
Safety and Industrial$2,759 $2,765 $5,491 $5,544 
Transportation and Electronics2,143 2,191 4,247 4,241 
Consumer1,263 1,293 2,403 2,485 
Corporate and Unallocated86 22 112 45 
Other4 12 18 23 
Total Company$6,255 $6,283 $12,271 $12,338 
BUSINESS SEGMENT INFORMATIONThree months ended
June 30,
Six months ended
June 30,
OPERATING INCOME (LOSS)
(Millions)2024202320242023
Safety and Industrial$612 $534 $1,269 $1,135 
Transportation and Electronics428 410 909 704 
Consumer219 235 435 414 
Corporate and Unallocated
Corporate special items:
Net costs for significant litigation(8)(10,357)(71)(10,439)
Divestiture costs(14)(1)(20)(4)
Russia exit (charges) benefits 18  18 
Total corporate special items(22)(10,340)(91)(10,425)
Other corporate (expense) income - net(2)(207)(73)(339)
Total Corporate and Unallocated(24)(10,547)(164)(10,764)
Other37 10 (28)19 
Total Company operating income (loss)1,272 (9,358)2,421 (8,492)
Other expense/(income), net(138)72 82 128 
Income (loss) before income taxes$1,410 $(9,430)$2,339 $(8,620)
Corporate and Unallocated and Other
Outside of 3M's operating segments, 3M has Corporate and Unallocated and Other which are not reportable business segments as they do not meet the segment reporting criteria. Because Corporate and Unallocated and Other include a variety of miscellaneous items, they are subject to fluctuation on a quarterly and annual basis.
Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense-net”.
Corporate special items include net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were also included in corporate special items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were not included in the Corporate net costs for significant litigation special item, instead being reflected in the Safety and Industrial business segment. Corporate special items for the periods presented also include divestiture costs and Russia exit costs/ benefits. Divestiture costs include costs that were not eligible to be part of discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture.
Other corporate expense-net includes certain enterprise and governance activities resulting in unallocated corporate costs and other activity and net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations, commercial activity with Solventum post-Separation, and certain operations of the former Health Care business segment retained by 3M.
8

3M Company and Subsidiaries
BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION - (CONTINUED)
(Unaudited)

Other principally reflects activity associated with:
Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with those previous divestitures.
Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Separation, as well as other applicable divestitures.
The table below provides disaggregated revenue information for full-year 2023 revised to reflect the changes to composition of segment information effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its business segments effective in the first quarter of 2024. Similar information relative to applicable periods will be included in 3M’s Form 10-Q filed for the second quarter of 2024. The information below should be read together with information in 3M’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Reports on Form 10-Q during the year ended December 31, 2023 (including the consolidated financial statements, notes thereto and Management’s Discussion and Analysis included in those documents), along with information included in 3M’s Current Reports on Form 8-K filed April 4, 2024. The financial information that follows does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary, unaudited, and based on current estimates, and remains subject to change.
Disaggregated revenue information
Net sales by division reflecting continuing operations (millions)2023
Abrasives$1,327
Automotive Aftermarket1,237
Electrical Markets1,285
Industrial Adhesives and Tapes2,051
Industrial Specialties1,180
Personal Safety3,382
Roofing Granules494
Total Safety and Industrial Business Segment10,956
Advanced Materials1,167
Automotive and Aerospace1,925
Commercial Branding and Transportation2,546
Electronics2,863
Total Transportation and Electronics Business Segment8,501
Consumer Safety and Well-Being1,096
Home and Auto Care1,260
Home Improvement1,448
Packaging and Expression1,222
Total Consumer Business Segment5,026
Corporate and Unallocated90
Other37
Total Company$24,610
Net sales by geographic area reflecting continuing operations (millions)2023
Americas$13,268 
Asia Pacific7,068 
Europe, Middle East and Africa4,274 
Worldwide$24,610 
9

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for special items is also provided:
Reasons 3M believes the measure is useful:
Net sales (and sales change)
Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items
Operating income (loss), segment operating income (loss) and operating income (loss) margin
Other expense (income), net
Income (loss) from continuing operations before taxes
Provision for income taxes and effective tax rate
Net income (loss) from continuing operations
Earnings (loss) per share from continuing operations
Additional non-GAAP measures:
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance
Adjusted EBITDA and adjusted EBITDA margin
Considered in evaluating and managing operations; meaningful in analyses of ongoing underlying operating trends
Net debt
Meaningful as indicator of liquidity and measure of capital structure strategy
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
10

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended June 30, 2023
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginOther expense (income), netIncome (loss) from continuing operations before taxesProvision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Safety and Industrial
GAAP amounts$534 19.3 %
Adjustments for special items:
Net costs for significant litigation80 
Total special items80 
Adjusted amounts (non-GAAP measures)4
$614 22.2 %
Transportation and Electronics
GAAP amounts$2,191 $410 18.7 %
Adjustments for special items:
Manufactured PFAS products(332)(41)
Total special items(332)(41)
Adjusted amounts (non-GAAP measures)4
$1,859 $369 19.8 %
Total Company
GAAP amounts$6,283 $(9,358)(148.9)%$72 $(9,430)$(2,261)24.0 %$(7,171)$(12.94)
Adjustments for special items:
Net costs for significant litigation5
— 10,437 (12)10,449 2,457 7,992 14.43 
Manufactured PFAS products(332)(41)— (41)(10)(31)(0.06)
Russia exit charges (benefits)— (18)— (18)(21)(0.04)
Divestiture costs— — — — 
Total special items(332)10,379 (12)10,391 2,450 7,941 14.33 
Adjusted amounts (non-GAAP measures)4
$5,951 $1,021 17.2 %$60 $961 $189 19.5 %$770 $1.39 
Three months ended June 30, 2024
(Dollars in millions, except per share amounts)Net salesSales changeOperating income (loss)Operating income (loss) marginOther expense (income), netIncome (loss) from continuing operations before taxesProvision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations Earnings per diluted share from continuing operations percent change
Safety and Industrial
GAAP amounts$612 22.2 %
Adjustments for special items:
Net costs for significant litigation11 
Total special items11 
Adjusted amounts (non-GAAP measures)4
$623 22.6 %
Transportation and Electronics
GAAP amounts$2,143 (2.2)%$428 20.0 %
Adjustments for special items:
Manufactured PFAS products(236)(2)
Total special items(236)(2)
Adjusted amounts (non-GAAP measures)4
$1,907 2.6 %$426 22.3 %
Total Company
GAAP amounts$6,255 (0.5)%$1,272 20.3 %$(138)$1,410 $203 14.4 %$1,204 $2.17 117 %
Adjustments for special items:
Net costs for significant litigation 19 (202)221 (25)246 0.44 
Manufactured PFAS products(236)(2) (2)(1)(1) 
Divestiture costs 14  14 (113)127 0.23 
Solventum ownership - change in value
  1,113 (1,113) (1,113)(2.00)
Pension risk transfer charge
  (795)795 188 607 1.09 
Total special items(236)31 116 (85)49 (134)(0.24)
Adjusted amounts (non-GAAP measures)4
$6,019 1.1 %$1,303 21.6 %$(22)$1,325 $252 19.1 %$1,070 $1.93 39  %
4These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
5For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for both basic and diluted loss per share in periods of resulting net losses.
11

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
Six months ended June 30, 2023
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginOther expense (income), netIncome (loss) from continuing operations before taxesProvision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Safety and Industrial
GAAP amounts$1,135 20.5 %
Adjustments for special items:
Net costs for significant litigation41 
Total special items41 
Adjusted amounts (non-GAAP measures)4
$1,176 21.2 %
Transportation and Electronics
GAAP amounts$4,241 $704 16.6 %
Adjustments for special items:
Manufactured PFAS products(677)(51)
Total special items(677)(51)
Adjusted amounts (non-GAAP measures)4
$3,564 $653 18.3 %
Total Company
GAAP amounts$12,338 $(8,492)(68.8)%$128 $(8,620)$(2,116)24.6 %$(6,509)$(11.76)
Adjustments for special items:
Net costs for significant litigation5
— 10,480 (12)10,492 2,464 8,028 14.51 
Manufactured PFAS products(677)(51)— (51)(13)(38)(0.07)
Russia exit charges (benefits)— (18)— (18)(21)(0.04)
Divestiture costs— — — 0.01 
Total special items(677)10,415 (12)10,427 2,454 7,973 14.41 
Adjusted amounts (non-GAAP measures)4
$11,661 $1,923 16.5 %$116 $1,807 $338 18.7 %$1,464 $2.65 
Six months ended June 30, 2024
(Dollars in millions, except per share amounts)Net salesSales changeOperating income (loss)Operating income (loss) marginOther expense (income), netIncome (loss) from continuing operations before taxesProvision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations Earnings per diluted share from continuing operations percent change
Safety and Industrial
GAAP amounts$1,269 23.1 %
Adjustments for special items:
Net costs for significant litigation18 
Total special items18 
Adjusted amounts (non-GAAP measures)4
$1,287 23.4 %
Transportation and Electronics
GAAP amounts$4,247 0.2 %$909 21.4 %
Adjustments for special items:
Manufactured PFAS products(517)(4)
Total special items(517)(4)
Adjusted amounts (non-GAAP measures)4
$3,730 4.7 %$905 24.3 %
Total Company
GAAP amounts$12,271 (0.5)%$2,421 19.7 %$82 $2,339 $423 18.1 %$1,909 $3.44 129 %
Adjustments for special items:
Net costs for significant litigation 89 (406)495 6 489 0.88 
Manufactured PFAS products(517)(4) (4)(2)(2) 
Divestiture costs 20  20 (111)131 0.24 
Solventum ownership - change in value  1,113 (1,113) (1,113)(2.01)
Pension risk transfer charge
  (795)795 188 607 1.09 
Total special items(517)105 (88)193 81 112 0.20 
Adjusted amounts (non-GAAP measures)4
$11,754 0.8 %$2,526 21.5 %$(6)$2,532 $504 19.9 %$2,021 $3.64 38  %
12

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
2024 forecast
2024 adjusted earnings per share from continuing operations (non-GAAP measure)4,6
$7.00 to $7.30
2024 adjusted effective tax rate (non-GAAP measure)4,6
19% to 20%
63M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”.
Three months ended June 30, 2024
Sales Change3
Organic salesAcquisitionsDivestituresTranslationTotal sales change
Total Company(0.3)%0.4 %0.8 %(1.4)%(0.5)%
Remove manufactured PFAS products special item impact1.5 — 0.1 — 1.6 
Adjusted total Company (non-GAAP measures)4
1.2 %0.4 %0.9 %(1.4)%1.1 %
Transportation and Electronics(1.3)%1.0 %— %(1.9)%(2.2)%
Remove manufactured PFAS products special item impact4.6 0.1 — 0.1 4.8 
Adjusted Transportation and Electronics (non-GAAP measures)4
3.3 %1.1 %— %(1.8)%2.6 %
By Geographic Area
Americas0.7 %0.5 %1.6 %(0.3)%2.5 %
Remove manufactured PFAS products special item impact0.3 — — 0.1 0.4 
Adjusted Americas (non-GAAP measures)4
1.0 %0.5 %1.6 %(0.2)%2.9 %
Asia Pacific0.6 %0.2 %0.1 %(4.0)%(3.1)%
Remove manufactured PFAS products special item impact3.0 (0.1)0.1 0.1 3.1 
Adjusted Asia Pacific (non-GAAP measures)4
3.6 %0.1 %0.2 %(3.9)%— %
Europe, Middle East & Africa(4.6)%— %0.1 %(0.7)%(5.2)%
Remove manufactured PFAS products special item impact2.6 0.1 — (0.1)2.6 
Adjusted Europe, Middle East & Africa (non-GAAP measures)4
(2.0)%0.1 %0.1 %(0.8)%(2.6)%
13

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Six months ended June 30, 2024
Sales Change3
Organic salesAcquisitionsDivestituresTranslationTotal sales change
Total Company(0.3)%0.4 %0.4 %(1.0)%(0.5)%
Remove manufactured PFAS products special item impact1.3 — — — 1.3 
Adjusted total Company (non-GAAP measures)4
1.0 %0.4 %0.4 %(1.0)%0.8 %
Transportation and Electronics0.6 %1.2 %— %(1.6)%0.2 %
Remove manufactured PFAS products special item impact4.3 0.2 — — 4.5 
Adjusted Transportation and Electronics (non-GAAP measures)4
4.9 %1.4 %— %(1.6)%4.7 %
By Geographic Area
Americas(0.6)%0.7 %0.8 %0.1 %1.0 %
Remove manufactured PFAS products special item impact0.6 — — — 0.6 
Adjusted Americas (non-GAAP measures)4
— %0.7 %0.8 %0.1 %1.6 %
Asia Pacific1.1 %0.1 %— %(4.0)%(2.8)%
Remove manufactured PFAS products special item impact2.6 — — — 2.6 
Adjusted Asia Pacific (non-GAAP measures)4
3.7 %0.1 %— %(4.0)%(0.2)%
Europe, Middle East & Africa(1.6)%— %(0.1)%0.4 %(1.3)%
Remove manufactured PFAS products special item impact1.3 0.1 (0.1)— 1.3 
Adjusted Europe, Middle East & Africa (non-GAAP measures)4
(0.3)%0.1 %(0.2)%0.4 %— %

Full-Year 2024 Forecast
Sales Change3
Organic salesAcquisitionsDivestituresTranslationTotal sales change
Total Company6
flat to +2%— %0.75 %(1)%(0.25%) to +1.75%
Remove manufactured PFAS products impact6
— — — — — 
Adjusted total Company (non-GAAP measures)4,6
flat to +2%— %0.75 %(1)%(0.25%) to +1.75%
14

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-GAAP measures):
Three months ended
June 30,
Six months ended
June 30,
Major GAAP Cash Flow Categories (dollars in millions)2024202320242023
Net cash provided by (used in) operating activities$1,021 $1,509 $1,788 $2,784 
Net cash provided by (used in) investing activities(463)(233)(856)(619)
Net cash provided by (used in) financing activities(1,358)(803)3,263 (1,519)
Three months ended
June 30,
Six months ended
June 30,
Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions)2024202320242023
Net cash provided by (used in) operating activities$1,021 $1,509 $1,788 $2,784 
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts122 101 473 159 
Divestiture costs after-tax payment impacts136 74 275 117 
Divestiture-related restructuring after-tax payment impacts1 2 
TCJA transition tax payment193 126 193 126 
Manufactured PFAS products impact after-tax payment impacts(58)(24)(128)(11)
Total adjustments for special items394 282 815 398 
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)7
$1,415 $1,791 $2,603 $3,182 
Purchases of property, plant and equipment (PPE)(269)(377)(644)(852)
Manufactured PFAS products impact - removing related purchases of PPE19 49 39 79 
Adjusted purchases of PPE (non-GAAP measure)7
$(250)$(328)$(605)$(773)
Adjusted free cash flow (non-GAAP measure)7
$1,165 $1,463 $1,998 $2,409 
Net income (loss) attributable to 3M$1,145 $(6,841)$2,073 $(5,865)
Adjustments for special items, net of tax:
Net costs for significant litigation 246 7,992 489 8,028 
Manufactured PFAS products impact (1)(31)(2)(38)
Russia exit charges (benefits) (21) (21)
Divestiture costs184 105 341 187 
Solventum ownership - change in value(1,113)— (1,113)— 
Pension risk transfer charge
607 — 607 — 
Total adjustments for special items, net of tax(77)8,045 322 8,156 
Net income (loss) attributable to 3M adjusted for special items
(used for adjusted free cash flow calculation)
$1,068 $1,204 $2,395 $2,291 
Adjusted free cash flow conversion (non-GAAP measure)7
109 %122 %83 %105 %
73M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations; accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued operations both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items (used for adjusted free cash flow calculation).
15

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures):
Adjusted EBITDA (non-GAAP measure)8
Adjusted EBITDA margin (non-GAAP measure)8
Three months ended
June 30,
Six months ended
June 30,
Three months ended
June 30,
Six months ended
June 30,
(Dollars in millions)20242023202420232024202320242023
Safety and Industrial$760 $746 $1,559 $1,442 27.6%27.0%28.4%26.0%
Transportation and Electronics510 446 1,072 807 26.8%23.9%28.8%22.6%
Consumer258 273 512 490 20.5%21.1%21.3%19.7%
Corporate and Unallocated and Other48 (164)(78)(238)
Total Company$1,576 $1,301 $3,065 $2,501 26.2%21.9%26.1%21.5%
Three months ended
June 30,
Six months ended
June 30,
Adjusted EBITDA (non-GAAP measure) (dollars in millions)2024202320242023
Adjusted net sales (non-GAAP measure)4
$6,019 $5,951 $11,754 $11,661 
Net income (loss) from continuing operations attributable to 3M1,204 (7,171)1,909 (6,509)
Add/(subtract):
Net income/(loss) attributable to noncontrolling interest6 11 10 
(Income)/loss from unconsolidated subsidiaries, net of taxes(3)(3)(4)(5)
Provision for income taxes203 (2,261)423 (2,116)
Other expense/(income):
Interest (Income)/expense179 97 410 179 
Pension & OPEB non-service cost (benefit)796 (25)785 (51)
Solventum ownership - change in value(1,113)— (1,113)— 
Depreciation and amortization (DA) expense302 311 592 638 
Adjustments for special items:
Net costs for significant litigation19 10,437 89 10,480 
Manufactured PFAS products impact:
Remove manufactured PFAS products operating (income) loss(2)(41)(4)(51)
Subtract PFAS-related amount included in DA above(29)(31)(53)(60)
Russia exit charges (benefits) (18) (18)
Divestiture costs14 20 
Total special items2 10,348 52 10,355 
Adjusted EBITDA (non-GAAP measure)8
$1,576 $1,301 $3,065 $2,501 
Adjusted EBITDA margin (non-GAAP measure)8
26.2 %21.9 %26.1 %21.5 %
83M defines adjusted EBITDA as net income (loss) from continuing operations attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest,(income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items.
16

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Adjusted EBITDA (non-GAAP measure)
Three months ended June 30, 2024 (dollars in millions)
Safety and IndustrialTransportation and ElectronicsConsumerCorporate and Unallocated and OtherTotal Company
Adjusted net sales (non-GAAP measure)4
$2,759 $1,907 $1,263 $90$6,019 
Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4
$623 $426 $219 $35 $1,303 
Add/(subtract):
Add depreciation and amortization (DA) expense137 113 39 13 302 
Subtract PFAS-related amount included in DA above (29)  (29)
Adjusted EBITDA (non-GAAP measure)8
$760 $510 $258 $48 $1,576 
Adjusted EBITDA margin (non-GAAP measure)8
27.6 %26.8 %20.5 %26.2 %
Three months ended June 30, 2023 (dollars in millions)
Adjusted net sales (non-GAAP measure)4
$2,765 $1,859 $1,293 $34 $5,951 
Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4
$614 $369 $235 $(197)$1,021 
Add/(subtract):
Add depreciation and amortization (DA) expense132 108 38 33 311 
Subtract PFAS-related amount included in DA above— (31)— — (31)
Adjusted EBITDA (non-GAAP measure)8
$746 $446 $273 $(164)$1,301 
Adjusted EBITDA margin (non-GAAP measure)8
27.0 %23.9 %21.1 %21.9 %
Six months ended June 30, 2024 (dollars in millions)
Adjusted net sales (non-GAAP measure)4
$5,491 $3,730 $2,403 $130$11,754 
Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4
$1,287 $905 $435 $(101)$2,526 
Add/(subtract):
Add depreciation and amortization (DA) expense272 220 77 23 592 
Subtract PFAS-related amount included in DA above (53)  (53)
Adjusted EBITDA (non-GAAP measure)8
$1,559 $1,072 $512 $(78)$3,065 
Adjusted EBITDA margin (non-GAAP measure)8
28.4 %28.8 %21.3 %26.1 %
Six months ended June 30, 2023 (dollars in millions)
Adjusted net sales (non-GAAP measure)4
$5,544 $3,564 $2,485 $68 $11,661 
Business segment operating income (measure of segment operating performance), adjusted for special items (non-GAAP measure)4
$1,176 $653 $414 $(320)$1,923 
Add/(subtract):
Add depreciation and amortization (DA) expense266 214 76 82 638 
Subtract PFAS-related amount included in DA above— (60)— — (60)
Adjusted EBITDA (non-GAAP measure)8
$1,442 $807 $490 $(238)$2,501 
Adjusted EBITDA margin (non-GAAP measure)8
26.0 %22.6 %19.7 %21.5 %
Net debt (non-GAAP measure):
Net Debt (non-GAAP measure)June 30, 2024December 31, 2023
Total debt$13,083 $16,035 
Less: Cash, cash equivalents and marketable securities10,372 5,805 
Net debt (non-GAAP measure)9
$2,711 $10,230 
9The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities all on a continuing operations basis.
17

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Reflecting Solventum as a discontinued operation for certain historical periods—amounts adjusted for special items (non-GAAP measures):
The tables below provide summaries of certain supplemental historical financial information (1) revised to reflect Solventum as a discontinued operation and (2) further adjusted for special items (non-GAAP measures).
This information should be read together with information in 3M’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Reports on Form 10-Q during the year ended December 31, 2023 (including the consolidated financial statements, notes thereto and Management’s Discussion and Analysis included in those documents), along with information included in 3M’s Current Reports on Form 8-K filed April 4, 2024. The financial information that follows does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary, unaudited, and based on current estimates, and remains subject to change.
The term "N/M" used herein references "not meaningful" for certain percent computations.
Reflecting Solventum as a discontinued operation
The table below provides a summary of certain supplemental financial information as revised to reflect the reclassification of Solventum’s net income to discontinued operations, thus reflecting the continuing operations of 3M.
Reflecting continuing operations
(Millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per share from continuing operations — diluted
Q1 2024$6,016 $1,149 19.1 %23.7 %$705 $1.27 
Q1 20236,055 866 14.3 17.9 662 1.20 
Q2 20236,283 (9,358)N/M24.0 (7,171)(12.94)
Q3 20236,270 (3,096)(49.4)23.5 (2,527)(4.56)
Q4 20236,002 899 15.0 3.9 634 1.14 
Full-Year 2023
24,610 (10,689)(43.4)25.4 (8,402)(15.17)
Full-Year 2022
26,161 4,369 16.7 4.5 4,013 7.07 
Full-Year 2021
27,224 4,929 18.1 17.1 3,935 6.72 
Reflecting Solventum as a discontinued operation — amounts adjusted for special items (non-GAAP measures)
The table below provides a summary of certain supplemental financial information adjusted for special items (non-GAAP measures) as revised to reflect the reclassification of Solventum’s net income to discontinued operations.
Continuing operations adjusted amounts (non-GAAP measures)
(Millions, except per share amounts)Net sales
Operating income
Operating income margin
Effective tax rate
Net income from continuing operations attributable to 3M
Earnings per share from continuing operations — diluted
Q1 2024$5,735 $1,223 21.3 %20.9 %$951 $1.71 
Q1 20235,710 902 15.8 17.7 694 1.26 
Q2 20235,951 1,021 17.2 19.5 770 1.39 
Q3 20235,978 1,292 21.6 24.8 934 1.68 
Q4 20235,682 1,129 19.9 13.6 948 1.70 
Full-Year 2023
23,321 4,344 18.6 19.2 3,346 6.04 
Full-Year 2022
24,810 4,717 19.0 16.6 3,796 6.69 
Full-Year 2021
25,966 5,257 20.2 17.5 4,188 7.15 
18

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
Three months ended March 31, 2024
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$6,016 $1,149 19.1 %$929 $220 23.7 %$705 $1.27 
Adjustments for special items:
Net costs for significant litigation— 70 274 31 243 0.44 
Manufactured PFAS products(281)(2)(2)(1)(1)— 
Divestiture costs— — 
Total special items(281)74 278 32 246 0.44 
Continuing operations adjusted amounts (non-GAAP measures)$5,735 $1,223 21.3 %$1,207 $252 20.9 %$951 $1.71 
Three months ended March 31, 2023
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$6,055 $866 14.3 %$810 $145 17.9 %$662 $1.20 
Adjustments for special items:
Net costs for significant litigation— 43 43 36 0.07 
Manufactured PFAS products(345)(10)(10)(3)(7)(0.01)
Divestiture costs— — — 
Total special items(345)36 36 32 0.06 
Continuing operations adjusted amounts (non-GAAP measures)$5,710 $902 15.8 %$846 $149 17.7 %$694 $1.26 
Three months ended June 30, 2023
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$6,283 $(9,358)N/M$(9,430)$(2,261)24.0 %$(7,171)$(12.94)
Adjustments for special items:
Net costs for significant litigation— 10,437 10,449 2,457 7,992 14.43 
Manufactured PFAS products(332)(41)(41)(10)(31)(0.06)
Russia exit charges (benefits)— (18)(18)(21)(0.04)
Divestiture costs— — — 
Total special items(332)10,379 10,391 2,450 7,941 14.33 
Continuing operations adjusted amounts (non-GAAP measures)$5,951 $1,021 17.2 %$961 $189 19.5 %$770 $1.39 
19

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Three months ended September 30, 2023
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$6,270 $(3,096)(49.4)%$(3,302)$(777)23.5 %$(2,527)$(4.56)
Adjustments for special items:
Net costs for significant litigation— 4,312 4,469 1,068 3,401 6.13 
Manufactured PFAS products(292)105 105 25 80 0.15 
Gain on business divestiture— (36)(36)(11)(25)(0.05)
Divestiture costs— 0.01 
Total special items(292)4,388 4,545 1,084 3,461 6.24 
Continuing operations adjusted amounts (non-GAAP measures)$5,978 $1,292 21.6 %$1,243 $307 24.8 %$934 $1.68 
Three months ended December 31, 2023
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$6,002 $899 15.0 %$651 $26 3.9 %$634 $1.14 
Adjustments for special items:
Net costs for significant litigation— 77 284 83 201 0.36 
Manufactured PFAS products(320)151 151 38 113 0.20 
Divestiture costs— — — 
Total special items(320)230 437 123 314 0.56 
Continuing operations adjusted amounts (non-GAAP measures)$5,682 $1,129 19.9 %$1,088 $149 13.6 %$948 $1.70 
Year ended December 31, 2023
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$24,610 $(10,689)(43.4)%$(11,271)$(2,867)25.4 %$(8,402)$(15.17)
Adjustments for special items:
Net costs for significant litigation— 14,869 15,245 3,615 11,630 21.00 
Manufactured PFAS products(1,289)205 205 50 155 0.28 
Gain on business divestitures— (36)(36)(11)(25)(0.05)
Russia exit charges (benefits)— (18)(18)(21)(0.04)
Divestiture costs— 13 13 0.02 
Total special items(1,289)15,033 15,409 3,661 11,748 21.21 
Continuing operations adjusted amounts (non-GAAP measures)$23,321 $4,344 18.6 %$4,138 $794 19.2 %$3,346 $6.04 
20

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Year ended December 31, 2022
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$26,161 $4,369 16.7 %$4,204 $188 4.5 %$4,013 $7.07 
Adjustments for special items:
Net costs for significant litigation— 2,291 2,291 476 1,815 3.20 
Manufactured PFAS products(1,351)631 631 121 510 0.90 
Gain on business divestitures— (2,724)(2,724)(39)(2,685)(4.73)
Russia exit charges (benefits)— 101 101 (2)103 0.19 
Divestiture-related restructuring actions— 41 41 32 0.05 
Divestiture costs— — 0.01 
Total special items(1,351)348 348 565 (217)(0.38)
Continuing operations adjusted amounts (non-GAAP measures)$24,810 $4,717 19.0 %$4,552 $753 16.6 %$3,796 $6.69 
Year ended December 31, 2021
Reflecting continuing operations
(Dollars in millions, except per share amounts)Net salesOperating income (loss)Operating income (loss) marginIncome (loss) from continuing operations before income taxes Provision (benefit) for income taxesEffective tax rateNet income (loss) from continuing operations attributable to 3MEarnings (loss) per diluted share from continuing operations
Reflecting continuing operations$27,224 $4,929 18.1 %$4,746 $813 17.1 %$3,935 $6.72 
Adjustments for special items:
Net costs for significant litigation— 463 463 104 359 0.61 
Manufactured PFAS products(1,258)(135)(135)(29)(106)(0.18)
Total special items(1,258)328 328 75 253 0.43 
Continuing operations adjusted amounts (non-GAAP measures)$25,966 $5,257 20.2 %$5,074 $888 17.5 %$4,188 $7.15 
Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along with the associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), and foreign tax credits. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Unallocated. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were reflected in corporate special items in Corporate and Unallocated. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were reflected as part of special items in the Safety and Industrial business segment. In the second quarter of 2024 and 2023, 3M reflected net payments of approximately $428 million and $129 million, respectively, related to net costs for significant litigation. In the first six months of 2024 and 2023, 3M made payments of approximately $799 million and $202 million, respectively, related to net costs for significant litigation.
21

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
Divestiture costs:
These include certain limited costs that were not eligible to be included within discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of update to 3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs that included within discontinued operations, including interest expense on debt issued by Solventum for the period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity structuring associated with the separation of Solventum. In the second quarter of 2024 and 2023, 3M made payments of approximately $58 million and $94 million, respectively, associated with divestiture costs. In the first six months of 2024 and 2023, 3M made payments of approximately $192 million and $148 million, respectively, associated with divestiture costs.
Gain on business divestitures:
In the third quarter of 2023, 3M recorded a gain related to the sale of its dental local anesthetic business partially offset by a loss associated with a previously contingent indemnification obligation from a 2020 divestiture.
In 2022, 3M recorded a gain related to the split-off and combination of its Food Safety business with Neogen Corporation.
Russia exit charges/benefits:
•    In the second quarter of 2023, 3M recorded a gain on final disposal of net assets in Russia. Previously, in the third quarter of 2022, 3M recorded a charge primarily related to impairment of these assets in connection with management's committed exit and disposal plan.
Divestiture-related restructuring actions:
In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the second quarter of 2023, 3M made payments of approximately $5 million associated with divestiture-related restructuring actions. In the first six months of 2024 and 2023, 3M made payments of approximately $2 million and $8 million, respectively, associated with divestiture-related restructuring actions.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA):
In the second quarter of 2024 and 2023, 3M made payments of approximately $193 million and $126 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments.
Pension risk transfer charge:
In the second quarter of 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income), net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance company.
Solventum ownership - change in value:
This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in other expense (income), net.
22


About 3M
3M (NYSE: MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news.
Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M’s news center and the social media channels such as @3M or @3MNews.
Contacts
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Diane Farrow, 612-202-2449
or
Eric Herron, 651-233-0043
Media Contact:
Sean Lynch, slynch2@mmm.com
23